NCT06319677View on ClinicalTrials.gov

PK/PD Study of Anti-Infective Drugs in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation Treatment

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

May 1, 2027

Study Completion Date

May 1, 2027

Conditions
Critical IllnessExtracorporeal Membrane Oxygenation Complication
Interventions
DEVICE

ECMO treatment

Critically ill patients were treated with ECMO while receiving antimicrobial therapy

Trial Locations (1)

Unknown

Xiangya Third Hospital, Central South University, Changsha

All Listed Sponsors
lead

The Third Xiangya Hospital of Central South University

OTHER

NCT06319677 - PK/PD Study of Anti-Infective Drugs in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation Treatment | Biotech Hunter | Biotech Hunter